Episodes featuring Merck

159 episodes, newest first.

Nov 12, 2026AI infrastructure faces its profitability testMad Money w/ Jim CramerNov 12, 2026
Nov 11, 2026Ro bets healthcare’s future on patient demand and softwareInvest Like the Best with Patrick O'ShaughnessyNov 11, 2026
Nov 10, 2026Anthropic IPO could reset the AI investment tradeMad Money w/ Jim CramerNov 10, 2026
Nov 9, 2026Biotech investors weigh obesity, RAS drugs and Moderna catalystsBreaking BiotechNov 9, 2026
Nov 6, 2026Calley Means says lobbying derailed the MAHA health agendaThe Joe Rogan ExperienceNov 6, 2026
Nov 3, 2026Nasdaq rebound tests market breadth as election risk risesStock Market Today With IBDNov 3, 2026
Nov 3, 2026Trump Links Economic Revival to National SecurityThe Dan Bongino ShowNov 3, 2026
Nov 2, 2026Amy Burroughs turned biotech uncertainty into negotiating powerTiger SistersNov 2, 2026
Nov 2, 2026Duke discovery pushes antibody therapy toward cancer trialsBusiness Of BiotechNov 2, 2026
Nov 1, 2026Investors test Novo, Moody’s, and Deckers against bear casesThe Investor's Podcast (We Study Billionaires) - The Investor’s Podcast NetworkNov 1, 2026
Oct 31, 2026Weekly charts turn market cycles into a risk-control systemThe TraderLion PodcastOct 31, 2026
Oct 31, 2026Cramer weighs tech volatility against portfolio diversificationMad Money w/ Jim CramerOct 31, 2026
Oct 30, 2026AI spending fears drive a technology-led market sell-offCNBC's "Fast Money"Oct 30, 2026
Oct 30, 2026AI financing fears deepen technology sell-offClosing BellOct 30, 2026
Oct 30, 2026AI sell-off tests tech leadership as investors seek safer groundClosing BellOct 30, 2026
Oct 30, 2026Cancer vaccine data meets market volatility at ESMOThe Readout LoudOct 30, 2026
Oct 29, 2026AI fears rattle Amazon, Intel and AlphabetCNBC's "Fast Money"Oct 29, 2026
Oct 29, 2026Drugmakers rally as tech earnings expose AI spending fault linesStock MoversOct 29, 2026
Oct 28, 2026Microsoft strength meets Alphabet’s search slowdownClosing BellOct 28, 2026
Oct 27, 2026U.S. and China rules redraw biotech dealmakingBioCentury This WeekOct 27, 2026
Oct 26, 2026Anthropic filing puts AI’s capital demands under the market’s microscopeClosing BellOct 26, 2026
Oct 26, 2026Moderna trial leads biotech week in reviewBreaking BiotechOct 26, 2026
Oct 26, 2026Nick Kokonas turns discomfort into a business strategyMy First MillionOct 26, 2026
Oct 26, 2026Human liver models challenge animal testing in drug developmentBusiness Of BiotechOct 26, 2026